What does united states — currency translation adjustment mean?

Reflects the impact of foreign currency exchange rate fluctuations on the valuation of assets and liabilities within the United States segment. Since this segment operates in the company's functional currency, this adjustment typically captures the impact of re-measuring foreign-denominated transactions or assets held by the domestic entity. It isolates the financial impact of global currency volatility on the U.S. segment's reported results.

Edwards Lifesciences EW United States — Currency translation adjustment

Other segment segments

Europe

$1.75M+333%

Rest of World

$0—

Similar metrics at other companies

FERGUnited States Segment — Effect of currency translation adjustment

$0+100%

VSTSUnited States — Translation

$0—

GLUnited American — Foreign exchange adjustment

$0—

LWNorth America — Foreign currency translation adjustment

$24.1M+3,113%

TFX

TFXAmericas — Currency translation adjustment

-$162K-139%

NSITNorth America — Foreign currency translation adjustment

$595.5K+161%

Other financials

Income statement

See full

Revenue$1.6B+16.7%

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$51.66B+19.3%

Enterprise value$49.92B+22.2%

P/E47.1×+36.8×

P/S8.2×+0.4×

Profitability

See full

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Edwards Lifesciences’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's united states — currency translation adjustment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's united states — currency translation adjustment?: Edwards Lifesciences (EW) reported united states — currency translation adjustment of $0 in Q4 2025.
What does united states — currency translation adjustment mean?: Reflects the impact of foreign currency exchange rate fluctuations on the valuation of assets and liabilities within the United States segment. Since this segment operates in the company's functional currency, this adjustment typically captures the impact of re-measuring foreign-denominated transactions or assets held by the domestic entity. It isolates the financial impact of global currency volatility on the U.S. segment's reported results.